US › Healthcare

OUTLOOK THERAPEUTICS INC (OTLK)

US · Healthcare · Biotechnology

$0.96+5.17%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$127,439
Net profit
$-4.5M
Profit YoY
+90.4%
EPS
$-0.17
EPS estimate
$-0.12
Net margin
-3,494.3%

EPS came in at -0.17 against a street estimate of -0.12 — a miss of 41.7%.

Key statistics

Market cap
$182.6M
Forward P/E
2.8
P/B
38.42
Book value
$-0.28
EPS (TTM)
$-1.14
52-week high
$3.39
52-week low
$0.16
50-day MA
$1.20
200-day MA
$0.93
Beta
0.78

Analyst view

Analysts rate OUTLOOK THERAPEUTICS INC a strong buy (5 buy, 1 hold, 0 sell out of 6) with an average price target of $5.40.

Shareholding

Insiders
14.97%
Institutions
5.77%

Largest institutional holders

FundStake
Armistice Capital, LLC2.23%
Vanguard Capital Management, LLC1.05%
Geode Capital Management, LLC0.32%
GILPIN WEALTH MANAGEMENT, LLC0.30%
BlackRock Inc0.26%
Warberg Asset Management LLC0.15%
Renaissance Technologies Corp0.14%
Nine Masts Capital Limited0.12%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for OUTLOOK THERAPEUTICS INC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.